Filed with ASX · · 2 pages · English
The meeting is scheduled to take place in late November and will be held in Sydney. Shareholders are encouraged to submit proxy forms and questions in advance of the meeting. The letter also provides information about the company and its subsidiary, Breathe Life Sciences.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Suite 506, Level 5 50 Clarence Street, Sydney NSW 2000, Australia hello@breathelifesciences.com +61 2 9078 8180 23 October 2026 ANNUAL GENERAL MEETING NOTICE AND PROXY FORM Dear Shareholder, The Annual General Meeting (Meeting) of shareholders of Bioxyne Limited (ACN 084 464 193) (Company) will be...
BLS Pharmaceuticals Limited on 6ix